Evotec creates long-term growth opportunities by initiating “Campus Levi-Montalcini” in Verona

  • Evotec SE today announced that Evotec has added significant opportunities for further, long-term growth by acquiring the Verona site from GlaxoSmithKline SpA. During a site meeting, the employees also decided on a new name for their campus. In commemoration of Italian Nobel laureate Rita Levi-Montalcini, the Verona site will be named “Campus Levi-Montalcini” going forward. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-creates-long-term-growth-opportunities-by-initiating-campus-levi-montalcini-in-verona-6076

    Du magst vielleicht auch